WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Stock Ownership - Who owns Novavax?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novavax Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Patrick KellyEVP CFO and Treasurer2026-03-075,904$9.98
$58.92kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0322,429$9.49
$212.85kSell
Mark J. CaseyEVP Chief Legal Officer2026-03-0311,378$9.49
$107.98kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
Ruxandra DraghiaakliEVP Research Development2026-03-0311,313$9.49
$107.36kSell
John C. JacobsPresident and CEO2026-03-0369,288$9.49
$657.54kSell
James Patrick KellyEVP CFO and Treasurer2026-03-0320,850$9.49
$197.87kSell
Elaine OharaEVP Chief Strategy Officer2026-03-0110,969$10.14
$111.23kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell
John C. JacobsPresident and CEO2026-03-0138,450$10.14
$389.88kSell

1 of 2

NVAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVAX insiders and whales buy or sell their stock.

NVAX Shareholders

What type of owners hold Novavax Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shah Capital Management9.03%14,845,097$135.54MInstitution
Blackrock Inc7.81%12,844,319$117.27MInstitution
Cadila Pharmaceuticals Ltd5.78%9,500,000$86.74MInsider
State Street Corp5.46%8,970,518$81.90MInstitution
D E Shaw Co Inc4.69%7,709,858$70.39MInstitution
Vanguard Portfolio Management LLC4.35%7,151,625$65.29MInstitution
Vanguard Capital Management LLC4.34%7,130,147$65.10MInstitution
Sanofi4.18%6,880,481$62.82MInstitution
Bank Of America Corp4.04%6,637,213$60.60MInstitution
James B. 1. Tananbaum3.81%6,268,455$57.23MInsider

1 of 3

NVAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVAX71.75%17.12%Net Selling
SLS29.01%5.59%Net Selling
ATAI27.07%32.65%Net BuyingNet Buying
ARDX42.55%57.45%Net SellingNet Selling
AVBP80.88%19.12%Net Selling
View Top Biotech Stocks

Novavax Stock Ownership FAQ

Who owns Novavax?

Novavax (NASDAQ: NVAX) is owned by 71.75% institutional shareholders, 17.12% Novavax insiders, and 11.12% retail investors. Cadila Pharmaceuticals Ltd is the largest individual Novavax shareholder, owning 9.50M shares representing 5.78% of the company. Cadila Pharmaceuticals Ltd's Novavax shares are currently valued at $86.74M.

If you're new to stock investing, here's how to buy Novavax stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.